Join
Live feed
·
INSIDERFilingvia Quantisnow
ANI Pharmaceuticals Inc. logo

HEAD OF R&D, COO-NOVITIUM OPS Shanmugam Muthusamy covered exercise/tax liability with 2,898 shares, decreasing direct ownership by 3% to 89,940 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ANIP· ANI Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ANIP (ANI Pharmaceuticals Inc.) and more on Quantisnow.